Inventor
DOUTY BRENT
US25 patents
⚠️ This page may combine multiple inventors who share the name “DOUTY BRENT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INCYTE CORP
24 patentsUS9707233B2Jul 18, 2017
Heterocyclylamines as PI3K inhibitors
INCYTE CORP23 citations98
US10138248B2Nov 27, 2018
Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines, substituted imidazo[1,2-b]pyridazines and substituted imidazo[1,2-a]pyrazines as PI3K-γ inhibitors
INCYTE CORP36 citations94
US10092570B2Oct 9, 2018
Heterocyclylamines as PI3K inhibitors
INCYTE CORP17 citations94
US9918990B2Mar 20, 2018
Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitors
INCYTE CORP23 citations94
US9730939B2Aug 15, 2017
Heterocyclylamines as PI3K inhibitors
INCYTE CORP23 citations94
US9399640B2Jul 26, 2016
Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitors
INCYTE CORP37 citations94
US10376513B2Aug 13, 2019
Heterocyclylamines as PI3K inhibitors
INCYTE CORP12 citations93
US11433071B2Sep 6, 2022
Heterocyclylamines as PI3K inhibitors
INCYTE CORP3 citations84
US10975088B2Apr 13, 2021
Imidazo[2,1-f][1,2,4]triazine compounds as pi3k-y inhibitors
INCYTE CORP6 citations84
US10738057B2Aug 11, 2020
Tertiary alcohols as PI3K-γ inhibitors
INCYTE CORP5 citations84
US10479795B2Nov 19, 2019
Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines and substituted imidazo[1,2-b]pyridazines as PI3K-gamma inhibitors
INCYTE CORP13 citations84
US9932341B2Apr 3, 2018
Use of pyrazolopyrimidine derivatives for the treatment of PI3K-delta related disorders
INCYTE CORP9 citations84
US11780840B2Oct 10, 2023
Tricyclic urea compounds as JAK2 V617F inhibitors
INCYTE CORP4 citations74
US11926630B2Mar 12, 2024
Tertiary alcohols as PI3K-γ inhibitors
INCYTE CORP2 citations73
US11819505B2Nov 21, 2023
Heterocyclylamines as PI3K inhibitors
INCYTE CORP1 citations73
US11225486B2Jan 18, 2022
Tertiary alcohols as PI3K-γ inhibitors
INCYTE CORP4 citations73
US11186580B2Nov 30, 2021
Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitor
INCYTE CORP4 citations73
US11046658B2Jun 29, 2021
Aminopyrazine derivatives as PI3K-γ inhibitors
INCYTE CORP4 citations72
US12152033B2Nov 26, 2024
Use of pyrazolopyrimidine derivatives for the treatment of PI3K-δ related disorders
INCYTE CORP0 citations63
US12516065B2Jan 6, 2026
Tertiary alcohols as PI3K-γ inhibitors
INCYTE CORP0 citations62
US12421197B2Sep 23, 2025
Aminopyrazine derivatives as PI3K-γ inhibitors
INCYTE CORP0 citations62
US12173006B2Dec 24, 2024
Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitor
INCYTE CORP1 citations62
US12030885B2Jul 9, 2024
Substituted imidazo[2,1-f][1,2,4]triazines as PI3K-gamma inhibitors
INCYTE CORP0 citations62
US11661422B2May 30, 2023
Tricyclic urea compounds as JAK2 V617F inhibitors
INCYTE CORP1 citations62